1. Home
  2. KRMD vs MSLE Comparison

KRMD vs MSLE Comparison

Compare KRMD & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

N/A

Current Price

$3.03

Market Cap

192.5M

Sector

Health Care

ML Signal

N/A

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$8.55

Market Cap

186.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KRMD
MSLE
Founded
1980
2018
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
186.9M
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
KRMD
MSLE
Price
$3.03
$8.55
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$6.25
★ $26.25
AVG Volume (30 Days)
★ 226.7K
47.2K
Earning Date
11-11-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.85
N/A
EPS
N/A
★ N/A
Revenue
★ $41,127,366.00
N/A
Revenue This Year
$16.78
N/A
Revenue Next Year
$17.22
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 22.23
N/A
52 Week Low
$2.98
$5.44
52 Week High
$6.61
$13.39

Technical Indicators

Market Signals
Indicator
KRMD
MSLE
Relative Strength Index (RSI) 24.92 37.58
Support Level N/A $8.11
Resistance Level $3.41 $8.59
Average True Range (ATR) 0.13 0.41
MACD -0.02 -0.09
Stochastic Oscillator 3.06 1.76

Price Performance

Historical Comparison
KRMD
MSLE

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: